Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48,324,727
-
Total 13F shares
-
512,614
-
Share change
-
+14,167
-
Total reported value
-
$4,392,713
-
Price per share
-
$8.57
-
Number of holders
-
16
-
Value change
-
+$236,954
-
Number of buys
-
12
-
Number of sells
-
4
Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q4 2023
As of 31 Dec 2023,
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
512,614 shares.
The largest 10 holders included
SAPIENT CAPITAL LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HOHIMER WEALTH MANAGEMENT, LLC, Sigma Planning Corp, Mesirow Financial Investment Management, Inc., HRT FINANCIAL LP, STATE STREET CORP, BlackRock Inc., and Qube Research & Technologies Ltd.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.